Potts Chicken Stock in 100% Recyclable Can 500ml | Pack of 2

Product Information

a b c d e f g h i Raj SR (June 2013). "Postural tachycardia syndrome (POTS)". Circulation. 127 (23): 2336–2342. doi: 10.1161/CIRCULATIONAHA.112.144501. PMC 3756553. PMID 23753844. Chang AR, Vadas P (2019). "Prevalence of Symptoms of Mast Cell Activation in Patients with Postural Orthostatic Tachycardia Syndrome and Hypermobile Ehlers-Danlos Syndrome". Journal of Allergy and Clinical Immunology. 143 (2): AB182. doi: 10.1016/j.jaci.2018.12.558. There may be a loss of neurovascular coupling and reduced functional hyperemia in response to cognitive challenge under orthostatic stress – perhaps related to a loss of autoregulatory buffering of beat-by-beat fluctuations in arterial blood flow. [47] Causes [ edit ] a b Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP (2011). "Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience". Cardiology Journal. 18 (5): 527–531. doi: 10.5603/cj.2011.0008. PMID 21947988. Knight J (2018). "Effects of Bedrest: Introduction and the Cardiovascular System". Nursing Times. 114 (12): 54–57. Archived from the original on 2022-08-10 . Retrieved 2022-08-10– via EMAP.

Central Adelaide Multidisciplinary Ambulatory Consulting Service (MACS) Outpatient Service" (PDF). Government of South Australia. Archived (PDF) from the original on 2017-03-03 . Retrieved 2017-03-03. Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G (December 2006). "Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine". Clinical Autonomic Research. 16 (6): 390–395. doi: 10.1007/s10286-006-0373-0. PMID 17036177. S2CID 22288783. The two drugs had similar potencies; combination therapy was not significantly better than monotherapy. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, etal. (October 2000). "The neuropathic postural tachycardia syndrome". The New England Journal of Medicine. 343 (14): 1008–1014. doi: 10.1056/NEJM200010053431404. PMID 11018167. a b Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, etal. (June 2021). "Long-COVID postural tachycardia syndrome: an American Autonomic Society statement". Clinical Autonomic Research. 31 (3): 365–368. doi: 10.1007/s10286-021-00798-2. PMC 7976723. PMID 33740207. a b Busmer L (2011). "Postural orthostatic tachycardia syndrome: Lorna Busmer explains how nurses in primary care can recognise the symptoms of this poorly understood condition and offer effective treatment". Primary Health Care. 21 (9): 16–20. doi: 10.7748/phc2011.11.21.9.16.c8794.Low PA, Novak V, Spies JM, Novak P, Petty GW (February 1999). "Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS)". The American Journal of the Medical Sciences. 317 (2): 124–133. doi: 10.1016/s0002-9629(15)40486-0. PMID 10037116. Arnold AC, Okamoto LE, Diedrich A, Paranjape SY, Raj SR, Biaggioni I, Gamboa A (May 2013). "Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study". Neurology. 80 (21): 1927–1933. doi: 10.1212/WNL.0b013e318293e310. PMC 3716342. PMID 23616163. Sivan M, Corrado J, Mathias C (2022-08-08). "The adapted Autonomic Profile (aAP) home-based test for the evaluation of neuro-cardiovascular autonomic dysfunction". ACNR, Advances in Clinical Neuroscience and Rehabilitation. doi: 10.47795/qkbu6715. Archived from the original on 2023-05-16 . Retrieved 2023-05-16.

Crnošija L, Krbot Skorić M, Adamec I, Lovrić M, Junaković A, Mišmaš A, etal. (February 2016). "Hemodynamic profile and heart rate variability in hyperadrenergic versus non-hyperadrenergic postural orthostatic tachycardia syndrome". Clinical Neurophysiology. 127 (2): 1639–1644. doi: 10.1016/j.clinph.2015.08.015. PMID 26386646. S2CID 6008891. a b c Bogle JM, Goodman BP, Barrs DM (May 2017). "Postural orthostatic tachycardia syndrome for the otolaryngologist". The Laryngoscope. 127 (5): 1195–1198. doi: 10.1002/lary.26269. PMID 27578452. S2CID 24233032. Goldstein DS, Smith LJ (2002). NDRF Hans. The National Dysautonomia Research Foundation. Archived from the original on 2021-05-04 . Retrieved 2020-10-03.Arnold AC, Haman K, Garland EM, Raj V, Dupont WD, Biaggioni I, etal. (January 2015). "Cognitive dysfunction in postural tachycardia syndrome". Clinical Science. 128 (1): 39–45. doi: 10.1042/CS20140251. PMC 4161607. PMID 25001527. Cui YX, DU JB, Zhang QY, Liao Y, Liu P, Wang YL, Qi JG, Yan H, Xu WR, Liu XQ, Sun Y, Sun CF, Zhang CY, Chen YH, Jin HF (October 2022). "[A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children]". Beijing Da Xue Xue Bao Yi Xue Ban (in Chinese). 54 (5): 954–960. doi: 10.19723/j.issn.1671-167X.2022.05.024. PMC 9568388. PMID 36241239. Pyridostigmine has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. [91] [21] a b McDonald C, Frith J, Newton JL (March 2011). "Single centre experience of ivabradine in postural orthostatic tachycardia syndrome". Europace. 13 (3): 427–430. doi: 10.1093/europace/euq390. PMC 3043639. PMID 21062792.

Yu X, Li H, Murphy TA, Nuss Z, Liles J, Liles C, etal. (April 2018). "Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome". Journal of the American Heart Association. 7 (8). doi: 10.1161/JAHA.117.008351. PMC 6015435. PMID 29618472. a b Tahir F, Bin Arif T, Majid Z, Ahmed J, Khalid M (April 2020). "Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature". Cureus. 12 (4): e7868. doi: 10.7759/cureus.7868. PMC 7255540. PMID 32489723. Schondorf R, Low PA (January 1993). "Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?". Neurology. 43 (1): 132–137. doi: 10.1212/WNL.43.1_Part_1.132. PMID 8423877. S2CID 43860206. While people with POTS typically have normal or even elevated arterial blood pressure, the neuropathic form of POTS is presumed to constitute a selective sympathetic venous denervation. [87] In these patients the selective Alpha-1 adrenergic receptor agonist midodrine may increase venous return, enhance stroke volume, and improve symptoms. [87] Midodrine should only be taken during the daylight hours as it may promote supine hypertension. [87]a b Miller AJ, Doherty TA (October 2019). "Hop to It: The First Animal Model of Autoimmune Postural Orthostatic Tachycardia Syndrome". Journal of the American Heart Association. 8 (19): e014084. doi: 10.1161/JAHA.119.014084. PMC 6806054. PMID 31547756. POTS: Causes, Symptoms, Diagnosis & Treatment". Cleveland Clinic. Archived from the original on 2021-11-12 . Retrieved 2020-04-04.